Shire Successfully Completes Tender Offer for ViroPharma PR Newswire DUBLIN, January 24, 2014 DUBLIN, January 24, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces the successful...
Shire Successfully Completes Tender Offer for ViroPharma PR Newswire DUBLIN, January 24, 2014 DUBLIN, January 24, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces the successful...
Tractor Supply Set to Join the S&P 500; Align Technology to Join MidCap 400; Roadrunner Transportation and Boise Cascade to Join S&P SmallCap 600 PR Newswire NEW YORK, Jan. 16, 2014 NEW...
Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. PR Newswire DUBLIN, January 15, 2014 DUBLIN, January 15, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG...
Shire Extends Tender Offer for ViroPharma PR Newswire DUBLIN, January 10, 2014 DUBLIN, January 10, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has extended the...
Shire Extends Tender Offer for ViroPharma PR Newswire DUBLIN, December 27, 2013 DUBLIN, December 27, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has extended the...
Hart-Scott-Rodino Waiting Period Expires for Shire's Acquisition of ViroPharma PR Newswire DUBLIN, Ireland, December 11, 2013 DUBLIN, Ireland, December 11, 2013 /PRNewswire/ -- Shire plc (LSE:...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales